Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Journal of Allergy and Clinical Immunology, 2025
Analysis of airway inflammation demonstrates a mechanism for T2-biologic failure in asthma

McDowell P., Azim A., Busby J. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologySerumSputum

Cell Reports, 2025
Maternal obesity impairs fetal brown adipogenesis by attenuating fetal FGF21 signaling

Hua L., Shen W., Gao D. et al.

Olink Target 48 MouseMetabolic DiseasesPathophysiologyMouse Serum

Scientific Reports, 2025
Genetic prediction of immune cells, inflammatory proteins, and metabolite-mediated association between gut microbiota and COPD: a Mendelian randomization study

Chen G., Jin Y., Chu C. et al.

Olink Target 96Respiratory DiseasesPathophysiologyPlasma

PLOS One, 2025
Identification of plasma proteins associated with seizures in epilepsy: A consensus machine learning approach

Ashtiani S., Akel S., Banote R. et al.

Olink Target 96NeurologyPatient StratificationPlasma

Scientific Reports, 2025
Childhood obesity and insulin resistance is correlated with gut microbiome serum protein: an integrated metagenomic and proteomic analysis

Liu L., Li M., Qin Y. et al.

Olink Target 96Metabolic DiseasesPathophysiologySerum

Vaccine, 2025
AS01-adjuvanted vaccine alters baseline correlates of T cell response to varicella zoster virus in older adults

Chan C., Ooi J., Koh C. et al.

Olink Target 48Infectious DiseasesPathophysiologySerum

Journal of Affective Disorders, 2025
Integrating metabolomics, proteomics, and traditional risk factors to predict sleep disorders and elucidate potential biological pathways

Zhang R., Luo J., Wang T. et al.

Olink Explore 3072/384NeurologyPathophysiologyPatient StratificationPlasma

npj Precision Oncology, 2025
The responses of HNSCC patients to immunotherapy are shown by two novel co-expression patterns

Daher-Ghanem N., Sharon S., Tao D. et al.

Olink Target 96OncologyImmunotherapyPatient StratificationTissue Supernatant

Nature Communications, 2025
The postbiotic ReFerm® versus standard nutritional support in advanced alcohol-related liver disease (GALA-POSTBIO): a randomized controlled phase 2 trial

Hansen J., Israelsen M., Nishijima S. et al.

Olink Target 96HepatologyPathophysiologyPlasma

Scientific Reports, 2025
Proteomic risk scores for predicting common diseases using linear and neural network models in the UK biobank

Smith A., Elliott P., Mayr M. et al.

Olink Explore 3072/384Wider Proteomics StudiesPatient StratificationPlasma

Nature Communications, 2025
Air pollution-induced proteomic alterations increase the risk of child respiratory infections

Brustad N., Wang T., He S. et al.

Olink Target 96ObstetricsEnvironmental Health & ToxicologyPathophysiologyPatient StratificationPlasma

Nature Communications, 2025
Shared genetic architecture of posttraumatic stress disorder with cardiovascular imaging, risk, and diagnoses

Shen J., Valentim W., Friligkou E. et al.

Olink Explore 3072/384CVDNeurologyCross-platform ValidationPlasma

International Journal of Molecular Sciences, 2025
Identification of Potential Therapeutic Targets for Coronary Atherosclerosis from an Inflammatory Perspective Through Integrated Proteomics and Single-Cell Omics

Wang H., Xie F., Wang M. et al.

Olink Explore 3072/384CVDPathophysiologyPlasma

BMC Neurology, 2025
Circulating inflammatory cytokines and the risk of myasthenia gravis: a bidirectional Mendelian randomization study

Su B., He Z., Shi L. et al.

Olink Target 96Immunological & Inflammatory DiseasesNeurologyPathophysiologyPlasma

Journal for ImmunoTherapy of Cancer, 2025
Phase II basket trial of Dual Anti-CTLA-4 and anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: pancreatic neuroendocrine neoplasm (PNEN) cohort

Patel S., Fisher J., Chae Y. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPlasma

The Journal of Clinical Endocrinology & Metabolism, 2025
Multiomics of Human Obesity and Related Multisystem Diseases

Anwar M., Highland H., Sheng Q. et al.

Olink Explore 3072/384Metabolic DiseasesPathophysiologyPlasma

International Journal of Surgery, 2025
Plasma proteomics profiles predict the risk of future aortic aneurysm and aortic dissection

Li M., He X., Gong W. et al.

Olink Explore 3072/384CVDPatient StratificationPlasma

Gut Microbes, 2025
Gut microbial metabolite butyrate suppresses hepatocellular carcinoma growth via CXCL11-dependent enhancement of natural killer cell infiltration

Zhang M., Huang X., Zhang Y. et al.

Olink Target 96OncologyPathophysiologyCell Culture Supernatant

Signal Transduction and Targeted Therapy, 2025
Reshaping the tumor microenvironment of cold soft-tissue sarcomas with anti-angiogenics: a phase 2 trial of regorafenib combined with avelumab

Toulmonde M., Guégan J., Spalato-Ceruso M. et al.

Olink Explore HTOncologyImmunotherapyPathophysiologyPlasma

Depression and Anxiety, 2025
Proteomic Biomarkers as Mediators in the Association Between Air Pollution and Incident Depression and Anxiety: Evidence From the UK Biobank

Wang M., Ma Y., Zheng Y. et al.

Olink Explore 3072/384NeurologyEnvironmental Health & ToxicologyPathophysiologyPlasma

3478 publications